Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "mast cell membrane proteins" refers collectively to all protein components located in the plasma membrane of mast cells. Mast cells are immune cells critical for allergic reactions, innate and adaptive immune functions, and protection against pathogens. These cells display a wide range of membrane proteins, including receptors (such as FcεRI, c-Kit), adhesion molecules, tetraspanins (e.g., CD9, CD63), and various adaptor proteins important for cellular activation, signal transduction, and interaction with the tissue environment. However, this term lacks specificity and does not refer to a unique molecular entity, limiting its utility as a singular therapeutic target. Key points: - "Mast cell membrane proteins" is not a canonical molecular target but a heterogeneous group. - The term is too broad and non-specific for structured database or drug targeting purposes. - More precise targets—such as "Fc epsilon RI", "c-Kit receptor (CD117)", "CD9", or "LAT"—should be used when describing drug targets or diagnostic markers on mast cells. - If your goal is to map to a target for structured data, you should select one specific mast cell surface protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast cell membrane proteins.